UK markets closed

ABIONYX Pharma SA (ABNX.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
1.0660+0.0160 (+1.52%)
At close: 04:55PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,750
5,252
675
0
Cost of revenue
4,217
4,616
416
0
Gross profit
533
636
259
0
Operating expenses
Research development
1,162
1,107
3,838
2,137
Selling general and administrative
1,315
1,321
586
562
Total operating expenses
4,415
4,745
6,211
2,968
Operating income or loss
-3,882
-4,109
-5,952
-2,968
Interest expense
65
61
8
0
Income before tax
-3,904
-4,206
-5,822
-1,886
Income tax expense
-
-
0
0
Income from continuing operations
-3,904
-4,206
-5,822
-1,886
Net income
-3,904
-4,206
-5,822
-1,886
Net income available to common shareholders
-3,904
-4,206
-5,822
-1,886
Basic EPS
-0.14
-0.15
-0.23
-0.08
Diluted EPS
-0.14
-0.15
-0.23
-0.08
Basic average shares
28,216
27,967
24,880
22,508
Diluted average shares
29,854
29,860
25,919
23,488